AMHERST MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: G82013 | SEVENOAKS, TN13 3AQ
Showing results 501-550 of 722
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Balsalazide sodium | 29 | 5,650 | £1.3K | +94.7% ▲ |
| Bempedoic acid | 29 | 952 | £1.8K | -11.5% ▼ |
| Etonogestrel | 29 | 29 | £2.3K | +0.3% vs avg |
| 29 | 1,230 | £1.1K | -28.5% ▼ | |
| Formoterol fumarate | 28 | 29 | £672 | +95.3% ▲ |
| Tafluprost and timolol | 28 | 960 | £464 | +45.9% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 28 | 28 | £349 | +157.7% ▲ |
| 28 | 3,700 | £519 | -28.1% ▼ | |
| Zinc oxide | 27 | 755 | £92 | +30.5% ▲ |
| Amiloride hydrochloride | 27 | 812 | £395 | +7.3% ▲ |
| Omega-3-acid ethyl esters | 27 | 2,520 | £1.2K | +27.8% ▲ |
| Mercaptopurine | 27 | 878 | £385 | +74.4% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 27 | 87.2K | £3.4K | +1.6% vs avg |
| Diclofenac sodium | 27 | 1,550 | £1.1K | +12.7% ▲ |
| 27 | 714 | £773 | +6.3% ▲ | |
| 27 | 2,354 | £3.8K | -20.1% ▼ | |
| Methylprednisolone acetate | 26 | 31 | £117 | -77.5% ▼ |
| 26 | 458 | £1.4K | +0.3% vs avg | |
| 26 | 323 | £962 | +23.0% ▲ | |
| 26 | 408 | £2.0K | -6.5% ▼ | |
| 26 | 560 | £466 | -0.2% vs avg | |
| Oxycodone hydrochloride/naloxone hydrochloride | 25 | 1,238 | £916 | +44.2% ▲ |
| Riluzole | 25 | 1,400 | £7.3K | +140.9% ▲ |
| Medroxyprogesterone acetate | 25 | 25 | £135 | -79.3% ▼ |
| Tube feed additive 1 kcal/ml higher protein liquid (0914051) | 25 | 1,068 | £1.6K | +84.0% ▲ |
| Gentamicin sulfate | 25 | 250 | £470 | +355.0% ▲ |
| Nepafenac | 25 | 118 | £369 | +302.6% ▲ |
| 25 | 454 | £998 | +110.8% ▲ | |
| 25 | 2,400 | £45 | -0.6% vs avg | |
| 25 | 61 | £233 | -19.4% ▼ | |
| 25 | 159 | £392 | +3.4% ▲ | |
| 25 | 1,770 | £276 | +114.1% ▲ | |
| 25 | 1,110 | £1.6K | +53.2% ▲ | |
| Olmesartan medoxomil/amlodipine | 24 | 672 | £387 | +81.9% ▲ |
| Rufinamide | 24 | 1,440 | £1.5K | +39.8% ▲ |
| Ciclosporin | 24 | 1,080 | £763 | +43.8% ▲ |
| Cinacalcet hydrochloride | 24 | 941 | £247 | +3.5% ▲ |
| Other compound vitamin/mineral formulation preparations | 24 | 914 | £52 | -25.1% ▼ |
| Azelastine hydrochloride | 24 | 638 | £285 | +114.1% ▲ |
| 24 | 52 | £722 | +391.9% ▲ | |
| 24 | 690 | £4.4K | +89.3% ▲ | |
| Acamprosate calcium | 23 | 3,780 | £423 | -34.0% ▼ |
| Erythromycin ethylsuccinate | 23 | 3,200 | £261 | -1.5% vs avg |
| Medroxyprogesterone acetate | 23 | 1,120 | £188 | -39.9% ▼ |
| Anastrozole | 23 | 840 | £31 | -74.7% ▼ |
| 23 | 1,460 | £361 | +56.3% ▲ | |
| 23 | 1,620 | £5.1K | -5.6% ▼ | |
| 23 | 1,400 | £128 | -51.3% ▼ | |
| Flupentixol hydrochloride | 22 | 451 | £62 | +0.3% vs avg |
| Estradiol valerate | 22 | 1,932 | £160 | +12.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.